How much is Delix Therapeutics worth in 2026?

Delix Therapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Delix Therapeutics raised?

Delix Therapeutics has raised $108.5M in total funding across 1 funding rounds.

Delix Therapeutics

Drug DiscoveryWebsite

Delix Therapeutics valuation and funding history | Last updated: September 3, 2021 | 1 funding rounds

Current Valuation

N/A

As of September 3, 2021

Total Funding Raised

$108.5M

Across 1 round

Last Round

Later Stage VC

$70.0M

Last Funding

Sep 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 3, 2021	Early Stage VC (Series A)	$70.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Delix Therapeutics is currently valued at N/A as of September 3, 2021. The company has raised a total of $108.5M in funding across 1 funding round.

Track Delix Therapeutics Valuation Updates

Get notified when Delix Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Delix Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Delix Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Delix Therapeutics Worth in 2026?

Delix Therapeutics is a leading private company in the Drug Discovery sector. Track Delix Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Delix Therapeutics Valuation is Determined

Private company valuations like Delix Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.